PRESS RELEASE published on 12/11/2024 at 07:29, 1 year 1 month ago Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo Nordisk Evotec SE announces selection of first projects for LAB eN² drug discovery accelerator with Novo Nordisk, focusing on cardiometabolic diseases from academic institutions Drug Discovery Evotec SE Novo Nordisk Cardiometabolic Diseases LAB EN²
BRIEF published on 11/29/2024 at 07:36, 1 year 2 months ago Evotec annonce le départ de son directeur opérationnel et une restructuration interne Changement De Direction Evotec Médicaments Départ Du COO Restructuration Interne
BRIEF published on 11/29/2024 at 07:36, 1 year 2 months ago Evotec Announces COO Departure and Internal Restructuring Pharmaceuticals Management Change Evotec COO Departure Internal Restructuring
PRESS RELEASE published on 11/29/2024 at 07:31, 1 year 2 months ago Evotec announces change in Management Board Evotec SE announces the departure of Chief Operating Officer Dr Craig Johnstone effective December 31, 2024, with internal distribution of responsibilities. Management praises Johnstone's contribution and commitment Global Operations Chief Operating Officer Evotec SE Management Board Dr Craig Johnstone
BRIEF published on 11/22/2024 at 17:00, 1 year 2 months ago Evotec SE commente le retrait de l'offre d'Halozyme Evotec SE Valeur Actionnariale Proposition D'acquisition Thérapeutique Halozyme Offre Sans Engagement
BRIEF published on 11/22/2024 at 17:00, 1 year 2 months ago Evotec SE Comments on Withdrawal of Halozyme's Offer Shareholder Value Evotec SE Acquisition Proposal Halozyme Therapeutics Non-binding Offer
PRESS RELEASE published on 11/22/2024 at 16:55, 1 year 2 months ago EQS-Adhoc: Comment on withdrawn non-binding offer Evotec SE acknowledges withdrawal of non-binding offer by Halozyme Therapeutics Inc. for acquisition. Management reiterates confidence in standalone strategy Acquisition Evotec SE Halozyme Therapeutics Inc. Withdrawn Offer Standalone Strategy
BRIEF published on 11/14/2024 at 22:56, 1 year 2 months ago Evotec SE répond à l'intérêt d'Halozyme Evotec SE Reprendre Thérapeutique Halozyme Manifestation D'intérêt 11 EUR Par Action
BRIEF published on 11/14/2024 at 22:56, 1 year 2 months ago Evotec SE Responds to Interest from Halozyme Evotec SE Takeover Halozyme Therapeutics Expression Of Interest EUR 11 Per Share
PRESS RELEASE published on 11/14/2024 at 22:51, 1 year 2 months ago EQS-Adhoc: Comment on media report Evotec SE receives non-binding expression of interest from Halozyme Therapeutics Inc. for a takeover offer of EUR 11.00 per share Evotec SE Takeover Offer Expression Of Interest Halozyme Therapeutics Inc. EUR 11.00 Per Share
Published on 02/11/2026 at 03:05, 1 hour 41 minutes ago CANEX Metals Announces Final Take Up of Gold Basin Shares and Expiry of Successful Gold Basin Offer
Published on 02/11/2026 at 01:00, 3 hours 46 minutes ago Kidoz Inc. Appoints John Nolie as Vice President of Sales, North America
Published on 02/10/2026 at 22:50, 5 hours 56 minutes ago Tectonic Metals Announces Financing of up to $40 Million
Published on 02/10/2026 at 22:15, 6 hours 31 minutes ago Earthwise Minerals Completes Private Placement and Makes Changes to the Management Team
Published on 02/10/2026 at 15:30, 13 hours 16 minutes ago Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/11/2026 at 02:30, 2 hours 15 minutes ago CGTN: Little Chinese New Year opens big window to China's soul
Published on 02/10/2026 at 23:33, 5 hours 12 minutes ago EQS-Adhoc: All for One Group SE: resolves on a public share buyback offer for up to 2.3% of the share capital and proposes to the Annual General Meeting an amended appropriation of retained earnings
Published on 02/10/2026 at 22:51, 5 hours 54 minutes ago Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc.
Published on 02/10/2026 at 22:28, 6 hours 17 minutes ago EQS-Adhoc: Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc.
Published on 02/10/2026 at 19:07, 9 hours 39 minutes ago Wacker Neuson Group publishes preliminary financial year 2025 figures and shows a positive outlook
Published on 02/10/2026 at 18:24, 10 hours 21 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 10 hours 21 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
Published on 02/10/2026 at 18:00, 10 hours 46 minutes ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie
Published on 02/10/2026 at 18:00, 10 hours 46 minutes ago CIS wins several strategic contracts in Africa, South America and Asia
